SCHEMBL7689381

SCHEMBL7689381

NCCCCn1c(CCOc2ccc(Cl)cc2)nc2ccccc21

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.70
TP53 P04637 8/20 0.70
MAPT P10636 3/20 0.70
POLB P06746 1/20 0.61
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
CXCL8 P10145 1/20 0.59
NOD1 Q9Y239 1/20 0.59
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
HTT P42858 1/20 0.58
RECQL P46063 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
GAA P10253 1/20 0.56
NPY1R P25929 1/20 0.55
RAB9A P51151 2/20 0.54
NPC1 O15118 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22080090 0.77 TP53 (0.66) SMN1; SMN2TP53MAPTCYP1A2CYP3A4
SCHEMBL7951612 0.75 NPY1R (0.71) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL7690343 0.75 NPY1R (0.71) SMN1; SMN2TP53MAPTKMT2ANPY1R
SCHEMBL7689046 0.74 CYP1A2 (0.66) SMN1; SMN2TP53MAPTPOLBCYP1A2
SCHEMBL20083834 0.72 MAPT (0.69) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL15085842 0.72 NPY1R (0.69) SMN1; SMN2TP53MAPTCYP1A2CYP3A4
SCHEMBL7689384 0.71 NPY1R (0.68) TP53NPY1R
SCHEMBL7684732 0.71 NPY1R (1.00) SMN1; SMN2TP53MAPTCYP1A2CYP3A4
Hydrochloric Acid SCHEMBL30282000 0.70 HIF1A (0.64) SMN1; SMN2MAPTCYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL29205453 0.70 HIF1A (0.64) SMN1; SMN2MAPTCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020007071-A1 Benzimidzolyl neuropeptide Y receptor antagonists BRITTON THOMAS CHARLES (US) 2002-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007071-A1 Benzimidzolyl neuropeptide Y receptor antagonists NPY1R, NPY2R, NPY5R SMN1; SMN2 2698/4885TP53 4432/4885MAPT 3175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.